racemetirosine has been researched along with Lung Diseases, Obstructive in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, KN | 1 |
| Larsson, SK | 1 |
| Beevers, DG | 1 |
| Bevan, PG | 1 |
| Hayes, B | 1 |
1 other study available for racemetirosine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Alpha-methyltyrosine in the management of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; alpha-Methyltyrosine; Antihypertensive Agents; Bronchiectasis; Femal | 1982 |